Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-088317
Filing Date
2025-09-08
Accepted
2025-09-08 17:08:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2524971-4_424b3.htm 424B3 212681
2 GRAPHIC lg_immuneering-4clr.jpg GRAPHIC 10129
  Complete submission text file 0001104659-25-088317.txt   227791
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-289997 | Film No.: 251300814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)